Loading…
Transition-to-Success Mentoring Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,674 other S bills in the 119th — cohort avg 32d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2026 · third_quarter · Health Issues
Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 1227 and S. 375
Client expense: Not reported · Firm income: $50,000
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Education
S. 299/H.R. 811, Mentoring to Succeed Act of 2025; S. 375, Transition to Success Mentoring Act of 2025; S. 377, Students Helping Young Students Act of 2025.
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 1227 and S. 375
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Education
S. 299/H.R. 811, Mentoring to Succeed Act of 2025; S. 375, Transition to Success Mentoring Act of 2025; S. 377, Students Helping Young Students Act of 2025.
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Education
S. 299/H.R. 811, Mentoring to Succeed Act of 2025; S. 375, Transition to Success Mentoring Act of 2025; S. 377, Students Helping Young Students Act of 2025.
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 1227 and S. 375
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Education
S. 299/H.R. 811, Mentoring to Succeed Act of 2025; S. 375, Transition to Success Mentoring Act of 2025; S. 377, Students Helping Young Students Act of 2025.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Education
S. 299/H.R. 811, Mentoring to Succeed Act of 2025; S. 375, Transition to Success Mentoring Act of 2025; S. 377, Students Helping Young Students Act of 2025.
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Education
S. 299/H.R. 811, Mentoring to Succeed Act of 2025; S. 375, Transition to Success Mentoring Act of 2025; S. 377, Students Helping Young Students Act of 2025.
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Education
S. 299/H.R. 811, Mentoring to Succeed Act of 2025; S. 375, Transition to Success Mentoring Act of 2025; S. 377, Students Helping Young Students Act of 2025.
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE